Problem: The National Cancer Institute publishes the Comprehensive Cancer Control Branch Program Evaluation Toolkit. On pages 25-29, the discussion centers on the identification and engagement of stakeholders.
What additional stakeholders might be valuable participants in the evaluation? What would they want to know?